Sunday, October 12, 2025
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

German American Bancorp Announces Quarterly Dividend and ExDividend Date

Elaine Mendonca by Elaine Mendonca
February 5, 2024
in Breaking News
0
Banking Trading online
0
SHARES
1
VIEWS
Share on FacebookShare on Twitter

On February 5, 2024, German American Bancorp (NASDAQ: GABC) made an exciting announcement regarding their quarterly dividend. This time, they have decided to distribute 27 cents per share to their valued shareholders. The ex-dividend date has been set for Thursday, indicating that the stock may open 27 cents lower on that particular day.

To be eligible for this dividend payout, investors must own GABC shares by the end of Wednesday’s session. The company has scheduled the dividend payment to be made on February 20, 2024. It’s interesting to note that once the dividends are received, investors have the freedom to either reinvest them back into the stock or utilize the payment in any other way they desire.

Taking a look at the stock’s previous close, it stood at $32.33. Over the past 52 weeks, the stock has fluctuated between a low of $24.85 and a high of $40.70. With a market cap of $960.908M, German American Bancorp continues to showcase its strength in the financial market. Additionally, the company offers an attractive forward dividend yield of 3.08%, making it an appealing choice for potential investors.

GABC Stock Analysis: Stable Performance and Positive Momentum as of February 5, 2024

On February 5, 2024, GABC stock closed at $31.47, marking a decrease of $0.71 or 2.21% since the previous market close. GABC is currently trading in the middle of its 52-week range, indicating a relatively stable performance over the long term. It is also trading above its 200-day simple moving average, suggesting positive momentum. GABC stock remained unchanged in after-hours trading. Investors should consider the overall context of the stock’s performance, monitor its performance, and consider other factors before making investment decisions. Thorough research and analysis are crucial in the volatile stock market.

GABC Stock Performance on February 5, 2024: Stable Outlook with Revenue, Net Income, and EPS Growth

On February 5, 2024, the stock performance of GABC showcased a steady outlook for the company. GABC has been able to maintain its revenue, net income, and earnings per share (EPS) since the previous quarter, while also demonstrating growth compared to the previous year.

Total revenue for GABC stood at $316.92 million over the past year, marking a 14.14% increase from the previous year. However, the total revenue remained flat at $82.61 million compared to the previous quarter.

Similarly, GABC’s net income also showcased stability and growth. The company reported a net income of $85.89 million over the past year, reflecting a 4.97% increase from the previous year. Just like the total revenue, the net income remained unchanged at $21.51 million compared to the previous quarter.

Earnings per share (EPS) also demonstrated positive growth for GABC. The EPS stood at $2.91 over the past year, reflecting a 4.63% increase from the previous year. Similar to the revenue and net income, the EPS held steady at $0.73 compared to the previous quarter.

Overall, GABC’s stock performance on February 5, 2024, suggests a stable and positive outlook for the company. Despite the revenue, net income, and EPS remaining flat since the previous quarter, they have all shown growth compared to the previous year. This indicates that GABC has been able to maintain its business performance and profitability, which is an encouraging sign for investors. However, potential investors should conduct further research and analysis to gain a comprehensive understanding of the company’s financial health and future prospects before making any investment decisions.

Tags: GABC
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Stock Market Today (1)

IBMs ExDividend Date and Implications for Shareholders

Improvement in Market Sentiment for BWX Technologies BWXT

Biotechnology Stock Bull Market

Analyst expresses optimism and raises price target for TG Therapeutics NASDAQTGTX

Recommended

Alibaba Stock

Alibaba Shares Face Headwinds Ahead of Quarterly Earnings Release

2 months ago

TakeTwo Interactive Software Inc Faces Stock Decline Due to Disappointing Performance

2 years ago
Occidental Petroleum Stock

Occidental Petroleum’s Strategic Pivot Faces Market Scrutiny

2 days ago
Money Express Stock

Money Express Stock at Critical Juncture Following Acquisition Bid

1 month ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple Applovin BigBear.ai BioNTech Broadcom Coinbase Eli Lilly Fiserv IBM Intel Kraft Heinz Lockheed Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Nike NIO Nvidia Ocugen Opendoor Oracle Oxford Lane Capital Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Super Micro Computer Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics Wolfspeed
No Result
View All Result

Highlights

Rockwell Medical Shares Plunge Amid Intensifying Sell-Off

Gold Fund Manager’s Shares Defy Sector Strength Amid Political Gridlock

FibroGen Shares Extend Decline Amid Mixed Analyst Outlook

Adicet Bio Shares Surge on Promising Clinical Trial Results and Capital Infusion

XpresSpa Group Shares Face Mounting Pressure Following Meeting Cancellation

Can Skillsoft Stock Reverse Its Steep Decline?

Trending

Ocuphire Pharma Stock
Analysis

Ocuphire Pharma: A Speculative Surge Defying Financial Fundamentals

by Andreas Sommer
October 12, 2025
0

While Ocuphire Pharma's stock celebrates a spectacular rally, reaching new annual peaks with a stunning 50% surge...

Wolfspeed Stock

Semiconductor Stock Surges Amid Retail Trading Frenzy

October 12, 2025
Hydrofarm Holdings Inc Stock

Hydrofarm Navigates Turbulent Waters Amid Financial Restructuring

October 12, 2025
Rockwell Medical Stock

Rockwell Medical Shares Plunge Amid Intensifying Sell-Off

October 12, 2025
US Global Investors Stock

Gold Fund Manager’s Shares Defy Sector Strength Amid Political Gridlock

October 12, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Ocuphire Pharma: A Speculative Surge Defying Financial Fundamentals
  • Semiconductor Stock Surges Amid Retail Trading Frenzy
  • Hydrofarm Navigates Turbulent Waters Amid Financial Restructuring

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com